Article Details

LianBio Completes Phase 1 Pharmacokinetic Study of Mavacamten in Healthy Chinese Volunteers

Retrieved on: 2022-05-09 19:01:39

Tags for this article:

Click the tags to see associated articles and topics

LianBio Completes Phase 1 Pharmacokinetic Study of Mavacamten in Healthy Chinese Volunteers. View article details on hiswai:

Excerpt

SHANGHAI, China and PRINCETON, N.J., May 09, 2022 (GLOBE NEWSWIRE) -- LianBio (Nasdaq: LIAN) a biotechnology company dedicated to bringing ...

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up